Trial Profile
Study of novel P2Y12 inhibitors in patients with acute myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- 13 Aug 2018 New trial record